ANNUAL PRODUCT REVIEW Patchara Kootiratrakarn Independent consultant.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Evaluation Plan in Hungary Dr. Tamás Tétényi Head of Department for Strategy and Evaluation National Development Agency.
Biopharmaceutical Quality
Transition from Q1- 8th to Q1- 9th edition
Annual Product Review (APR) Product Quality Review (PQR)
Ensuring Better Services and Fair Value “Introduction and roadmap to implementation of ISO in Zambia’s water utilities” Kasenga Hara March 2015.
Module 6 | Slide 1 of Contract Production, Analysis and other activities Section 7 Basic Principles of GMP.
 Contracts  Subcontracting  Suppliers  Complaints  Corrective and preventive actions (CAPA)  Internal audits  Management reviews Management requirements.
Learning from GMP Inspections. Richard Bateman QA Specialist Pharmacist East and South East England Specialist Pharmacy Services.
Quality Assurance. Function Quality program Quality Assurance –Covers everything from raw materials and GMP verification through finished-product release.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Roles and Responsibilities
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
1 PROCUREMENT AUTHORITY AND RESPONSEBILITIES Dr. Fred Mugambi Mwirigi JKUAT.
Good Manufacturing Practices for Blood Establishments
Management of Change Control. Overview Changes – Good or bad? Forced or voluntary? The Importance of Change Control Major Changes to both legacy company.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Seafood HACCP Alliance for Training and Education Chapter 10 Principle 6: Establish Verification Procedures.
© 2009 Michigan State University licensed under CC-BY-SA, original at Corrective Action.
Bodil Mose Pedersen, DHI Status for implementering af ”Quality Manual”
Quality Control Testing in Procurement Helene Möller, M.Pharm, PhD Interregional Seminar for Quality Control Laboratories involved in WHO Prequalification.
ASEAN GMP TRAINING MODULE PERSONNEL
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
World Health Organization
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
PRODUCT TRANSFER.
Supplier Maintenance and Development
Cavendish Scott, Inc. 1 Regulatory and Statutory Compliance: It’s Everybody’s Business! Diana Lough Cavendish Scott, Inc.
Kimberly A. Trautman FDA’s Medical Device Quality System Expert
Important informations
Module 6 | Slide 1 of Contract Production and Analysis Section 7 Basic Principles of GMP.
4.3 Document control 4.4 Review of requests, tenders and contracts
Molecule-to-Market-Place Quality
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
FDA Regulatory and Compliance Symposium
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
TOTAL QUALITY MANAGEMENT
19-Feb-16 “"Dana Confidential Information - Those having access to this work may not copy it, use it or disclose the information contained within this.
Most Common Deficiencies Cheryl O. Morton Managing Director, AIHA Laboratory Accreditation Programs, LLC.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
DOCUMENTATION ISO/IEC 17025:2005 Documentation.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Quality Control significance in pharmaceutical industry
© 2011 Pharmaceutical Consultancy Services, All Rights Reserved. Management Review Concordiaplein VV Haastrecht, the Netherlands Tel
ITRI Industrial Technology Research Institute The Audit Process of Medical Device GMP for Domestic Manufacturers DOH Designated Auditing Organizations.
Compliance Update Allergenic Products Advisory Committee Meeting March 15, 2002 Teddi Lopez DCM/OCBQ Center for Biologics Evaluation and Research.
November 6, 2013 Purchasing Controls & Supplier Quality Best Practices Beyond Compliance for the Medical Device Industry AdvaMed 2013 Bernie Liebler Technology.
Quality Management: Mutually beneficial supplier relationships.
External Provider Control
“Your sustainable compliance and remediation partners”
Software Quality Control and Quality Assurance: Introduction
ISO/IEC
CHANGE CONTROL.
MHRA GMP Inspection Deficiency Data Trend 2016
Quality Metrics for better Quality Compliance
Quality Assurance and Quality Control in Generics
Implementation Strategy July 2002
How to do an Internal Audit
Lesson 5: BRITE Seminar: GMP II
Food Production Systems
Introduction to GMP.
Quality Assurance.
Quality Assurance.
Quality Assurance.
HDV CO2 certification CoP provisions
Re-inspection of production sites: preparation of CAPA plans and their implementation GMP-inspection. Part , Quality director, Maklakova Olga.
Manufacture of Sterile Medicinal Products: ‘Annex 1’ - DRAFT
Presentation transcript:

ANNUAL PRODUCT REVIEW Patchara Kootiratrakarn Independent consultant

Definition Annual Product Review A compilation of identified critical data related to licensed products and intermediates manufactured at a local site

Responsibility QA manager Functional area managers Site Annual Product Review committee

QA manager To ensure that, responsible for: A system to compile APR’s exists, and is managed and maintained APRs are compiled on an annual basis, in compliance with the requirements of SOP Final approval of each APR report Evaluate data/ information comprising the APR, to assess trends, identify adverse trends, and determine the need for changes in specifications or manufacturing and or control process

QA Manager Co ordinate actions arising from information found in the APR reviewing process, and follow up on the proposed CAPA to implementation >>Responsibility

Functional area manager Providing data on time Analysis of data on time Recommendation for improvement as indicated by the SOP Implementation on CAPA proposal related to the department >>Responsibility

Site APR committee Site APR committee comprised of APR Report Author & Authorizer Managing Director QA and QC Managers Production Manager R&D Manager Planning and Supply Chain Manager Other concerned departments (Marketing manager, engineering manager etc)

Site APR committee Responsible for Review, evaluate APR and decide on CAPA and/or recommendations Approval of each APR final report Support and executing the agreed action plan based upon the APR

How to proceeds? Gather and evaluate raw data (department manager) Edit and APR report writing (QA department) Review and comment to the draft report (APR committee) Comment, conclude with CAPA proposal (APR committee) Present to APR committee (QA and related department) Final APR report approval (APR committee) CAPA implementation (department manager) Summarize in the next APR (QA department)

Outline of the APR report (1 of 3) Executive summary Introduction and product overview Manufacturing/ process data Review of raw materials and packaging materials Significant and related deviation Analysis of rejection Product testing and trend analysis Stability study and trend analysis

Outline of the APR report (2 of 3) Review of reference samples and retention samples Review of related changes Validation activities Technical & quality agreements Customer technical complaint/ Medical complaint Product return Product recall

Outline of the APR report (3 of 3) Complaint to supplier Regulatory activities Pharmacovigilance information Review of Corrective and Preventive actions Environment monitoring results Observation from external inspection Conclusion and recommendation